MedinCell S.A. (MDCLF) Financials
MDCLF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | ? | ? |
| Sept. 30, 2025 | 87.7 million | 123.7 million |
| March 31, 2025 | 97.9 million | 115.6 million |
| Sept. 30, 2024 | 65.6 million | 125.7 million |
MDCLF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | ? | ? |
| Sept. 30, 2025 | -17.0 million | ? |
| March 31, 2025 | -4.0 million | 1.9 million |
| Sept. 30, 2024 | 23.8 million | 1.3 million |
MDCLF Net Income
No data available :(
MDCLF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | - | - | - |
| Sept. 30, 2025 | 62.9 million | 59.7 million | 2.9 million |
| March 31, 2025 | 77.8 million | 53.5 million | 2.9 million |
| Sept. 30, 2024 | 43.3 million | 55.5 million | 3.2 million |
MDCLF Shares Outstanding
MDCLF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | - | 15.3 million | 12.7 million | - |
| Sept. 30, 2025 | 270416 | 14.7 million | 8.6 million | - |
| March 31, 2025 | 646037 | 15.2 million | 8.1 million | 1.7 million |
| Sept. 30, 2024 | 217158 | 11.4 million | 7.5 million | 1.9 million |
MDCLF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 9.1 million | - |
| Sept. 30, 2025 | 13.6 million | - |
| March 31, 2025 | 17.4 million | - |
| Sept. 30, 2024 | 10.5 million | - |
MDCLF
Price: $34.39
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.72 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 1.2 billion